Sonata Capital Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$404K Hold
336
0.13% 91
2026
Q1
$309K Sell
336
-25
-7% -$25.3K 0.11% 96
2025
Q4
$388K Buy
361
+50
+16% +$47.8K 0.14% 88
2025
Q3
$237K Buy
311
+1
+0.3% +$744 0.09% 116
2025
Q2
$242K Buy
+310
New +$241K 0.1% 109

Other funds holding LLY

Sonata Capital Group's LLY Position: Q2 2026 in Review

Sonata Capital Group held its Eli Lilly (LLY) position steady in Q2 2026 at 336 shares worth $404K. The position accounts for 0.13% of the portfolio, ranked #91.

Sonata Capital Group first reported a position in LLY in Q2 2025 and has held it in 5 quarters since. 2,247 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Sonata Capital Group held 336 shares of Eli Lilly worth $404K as of Q2 2026.
  • Sonata Capital Group left its Eli Lilly share count unchanged in Q2 2026.
  • Eli Lilly made up 0.13% of Sonata Capital Group's portfolio in Q2 2026, its #91 holding.
  • Sonata Capital Group first reported a position in Eli Lilly in Q2 2025 and has held it in 5 quarters since.
  • 2,247 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Sonata Capital Group's 13F filing for Q2 2026, filed 24 Jul 2026.